NCT06821880View on ClinicalTrials.gov

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Chronic Lymphocytic Leukaemia (CLL)Multiple Myeloma (MM)Secondary Immunodeficiency (SID)
Trial Locations (5)

6020

RECRUITING

Medizinische Universität Innsbruck, Innsbruck

6330

NOT_YET_RECRUITING

BKH Kufstein, Kufstein

8010

NOT_YET_RECRUITING

Medizinische Universität Graz, Graz

14195

NOT_YET_RECRUITING

Onkologischer Schwerpunkt am Oskar-Helene-Heim, Berlin

82467

NOT_YET_RECRUITING

Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen

All Listed Sponsors
lead

Medical University Innsbruck

OTHER